Neutral
AI recommendation signal analysis across 307 domains for the Neutral persona in Weight Loss Clinics GLP-1 Telehealth.
Many tables and charts on this page show only the top few results; the full data behind them runs far deeper. The complete report unlocks every row, chart, and download for this industry.
Get the full Weight Loss Clinics GLP-1 Telehealth report →How to use this page
Be where the profession is
The professional organizations search associates with this industry. Memberships and their member directories are trust signals and link sources.
Where the numbers come from
We run professional orgs queries for this industry through Google and aggregate every result: domains by rank-weighted score (higher positions count for more) and appearance count, exact URLs by appearance count, and the most common title phrases.
What's on this page
Domain and URL charts, the full result list, and title n-gram tables.
Research: Professional Orgs
Domains appearing in Google results for Neutral's Research: Professional Orgs queries. Score is a rank-weighted sum (higher-ranked appearances count for more); count is a plain appearance tally.
Top URLs
Individual pages (not just domains) ranked by the same rank-weighted score, labeled by page title.
All Results
Every result for Neutral's Research: Professional Orgs queries, ranked by how many times each exact URL appeared (ties broken by average rank position, so appearing higher up wins), a different aggregation than the score-based charts above. Title and URL links open in a new tab.
Title N-Grams
Most common word phrases (2 to 7 words) across every result title for these queries.
2-grams
| 60 | glp 1 |
| 31 | weight loss |
| 10 | of glp |
| 9 | loss drugs |
| 8 | 1 drugs |
| 8 | 1 weight |
| 6 | glp 1s |
| 6 | the glp |
| 5 | for obesity |
| 5 | 1 agonists |
| 4 | weight management |
| 4 | 1 revolution |
| 4 | for weight |
| 3 | 1 therapy |
| 3 | therapy for |
| 3 | drugs for |
| 3 | the obesity |
| 3 | 1 coverage |
| 3 | 1 medications |
| 3 | 1 collective |
| 2 | and glp |
| 2 | world health |
| 2 | health organization |
| 2 | organization recommends |
| 2 | recommends glp |
3-grams
| 9 | weight loss drugs |
| 8 | glp 1 drugs |
| 8 | of glp 1 |
| 8 | glp 1 weight |
| 6 | 1 weight loss |
| 6 | the glp 1 |
| 5 | glp 1 agonists |
| 4 | glp 1 revolution |
| 3 | glp 1 therapy |
| 3 | 1 therapy for |
| 3 | therapy for obesity |
| 3 | glp 1 coverage |
| 3 | glp 1 medications |
| 3 | for weight loss |
| 3 | glp 1 collective |
| 2 | and glp 1 |
| 2 | world health organization |
| 2 | health organization recommends |
| 2 | organization recommends glp |
| 2 | recommends glp 1 |
| 2 | 1 drugs for |
| 2 | drugs for obesity |
| 2 | the role of |
| 2 | role of glp |
| 2 | of glp 1s |
4-grams
| 6 | glp 1 weight loss |
| 4 | 1 weight loss drugs |
| 4 | the glp 1 revolution |
| 3 | glp 1 therapy for |
| 3 | 1 therapy for obesity |
| 3 | of glp 1 weight |
| 2 | world health organization recommends |
| 2 | health organization recommends glp |
| 2 | organization recommends glp 1 |
| 2 | recommends glp 1 drugs |
| 2 | glp 1 drugs for |
| 2 | 1 drugs for obesity |
| 2 | the role of glp |
| 2 | role of glp 1s |
| 2 | of glp 1s in |
| 2 | glp 1s in modern |
| 2 | 1s in modern weight |
| 2 | in modern weight loss |
| 2 | modern weight loss strategies |
| 2 | the future of glp |
| 2 | future of glp 1 |
| 2 | employer approaches to glp |
| 2 | approaches to glp 1 |
| 2 | to glp 1 coverage |
| 2 | rise of glp 1 |
5-grams
| 4 | glp 1 weight loss drugs |
| 3 | glp 1 therapy for obesity |
| 2 | world health organization recommends glp |
| 2 | health organization recommends glp 1 |
| 2 | organization recommends glp 1 drugs |
| 2 | glp 1 drugs for obesity |
| 2 | the role of glp 1s |
| 2 | role of glp 1s in |
| 2 | of glp 1s in modern |
| 2 | glp 1s in modern weight |
| 2 | 1s in modern weight loss |
| 2 | in modern weight loss strategies |
| 2 | the future of glp 1 |
| 2 | employer approaches to glp 1 |
| 2 | approaches to glp 1 coverage |
| 2 | rise of glp 1 weight |
| 2 | of glp 1 weight loss |
| 2 | people with obesity share perspectives |
| 2 | with obesity share perspectives on |
| 2 | obesity share perspectives on weight |
| 2 | share perspectives on weight loss |
| 2 | optimizing glp 1 therapy for |
| 2 | 1 therapy for obesity with |
| 2 | therapy for obesity with food |
| 2 | for obesity with food as |
6-grams
| 2 | world health organization recommends glp 1 |
| 2 | health organization recommends glp 1 drugs |
| 2 | the role of glp 1s in |
| 2 | role of glp 1s in modern |
| 2 | of glp 1s in modern weight |
| 2 | glp 1s in modern weight loss |
| 2 | 1s in modern weight loss strategies |
| 2 | employer approaches to glp 1 coverage |
| 2 | rise of glp 1 weight loss |
| 2 | of glp 1 weight loss drugs |
| 2 | people with obesity share perspectives on |
| 2 | with obesity share perspectives on weight |
| 2 | obesity share perspectives on weight loss |
| 2 | optimizing glp 1 therapy for obesity |
| 2 | glp 1 therapy for obesity with |
| 2 | 1 therapy for obesity with food |
| 2 | therapy for obesity with food as |
| 2 | for obesity with food as medicine |
| 2 | food companies are targeting users of |
| 2 | companies are targeting users of weight |
| 2 | are targeting users of weight loss |
| 2 | targeting users of weight loss drugs |
| 1 | obesity and glp 1 ras professional |
| 1 | and glp 1 ras professional education |
| 1 | glp 1 ras professional education hub |
7-grams
| 2 | world health organization recommends glp 1 drugs |
| 2 | the role of glp 1s in modern |
| 2 | role of glp 1s in modern weight |
| 2 | of glp 1s in modern weight loss |
| 2 | glp 1s in modern weight loss strategies |
| 2 | rise of glp 1 weight loss drugs |
| 2 | people with obesity share perspectives on weight |
| 2 | with obesity share perspectives on weight loss |
| 2 | optimizing glp 1 therapy for obesity with |
| 2 | glp 1 therapy for obesity with food |
| 2 | 1 therapy for obesity with food as |
| 2 | therapy for obesity with food as medicine |
| 2 | food companies are targeting users of weight |
| 2 | companies are targeting users of weight loss |
| 2 | are targeting users of weight loss drugs |
| 1 | obesity and glp 1 ras professional education |
| 1 | and glp 1 ras professional education hub |
| 1 | nutritional priorities to support glp 1 therapy |
| 1 | priorities to support glp 1 therapy for |
| 1 | to support glp 1 therapy for obesity |
| 1 | health organization recommends glp 1 drugs for |
| 1 | organization recommends glp 1 drugs for obesity |
| 1 | market overview glp 1 agonists and the |
| 1 | overview glp 1 agonists and the obesity |
| 1 | glp 1 agonists and the obesity market |